Duloxetine-induced Syndrome of Inappropriate Secretion of Antidiuretic Hormone in a Super-elderly Patient

Intern Med. 2022 Apr 1;61(7):1099-1103. doi: 10.2169/internalmedicine.7722-21. Epub 2021 Sep 11.

Abstract

Duloxetine is widely used for pain control and depressive syndromes. One of its potential side effects is syndrome of inappropriate secretion of antidiuretic hormone (SIADH). Duloxetine-induced SIADH causes hyponatremia, which leads to a variety of symptoms and has previously been reported in the elderly. In the present case, we experienced a case of the rapid onset of SIADH in a super-elderly woman receiving low-dose duloxetine. Elderly patients tend to have lower duloxetine doses and an earlier onset than non-elderly patients. When hyponatremia occurs after duloxetine administration, duloxetine-induced SIADH should be considered, especially in high-risk elderly patients, regardless of the duloxetine dose or duration of treatment.

Keywords: duloxetine; elderly; hyponatremia; syndrome of inappropriate secretion of antidiuretic hormone (SIADH).

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Duloxetine Hydrochloride / adverse effects
  • Female
  • Humans
  • Hyponatremia* / etiology
  • Inappropriate ADH Syndrome* / diagnosis
  • Middle Aged
  • Vasopressins / therapeutic use

Substances

  • Vasopressins
  • Duloxetine Hydrochloride